USPTO Deadlines
Next Deadline
990 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-07-26)
Due Date
July 26, 2028
Grace Period Ends
January 26, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 26, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jul 26, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jun 17, 2022 | OP.T | T | OPPOSITION TERMINATED NO. 999999 | Loading... |
| Jun 17, 2022 | OP.D | T | OPPOSITION DISMISSED NO. 999999 | Loading... |
| Jun 17, 2022 | TMBN | T | TTAB RELEASE CASE TO TRADEMARKS | Loading... |
| Feb 22, 2022 | OPPF | T | OPPOSITION PAPERS RECEIVED AT TTAB | Loading... |
| Feb 22, 2022 | OP.I | T | OPPOSITION INSTITUTED NO. 999999 | Loading... |
| Feb 22, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 22, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 2, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 20, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jan 20, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 19, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 18, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 18, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 19, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 19, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 19, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 12, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 2, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 7, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 040
Custom manufacture of pharmaceuticals by pharmaceutical compounders
First Use Anywhere:
May 1, 2020
First Use in Commerce:
May 1, 2020
Classification
International Classes
040
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"COST" AND "DRUG COMPANY"